Receptor Tyrosine Kinase Profiling

Patent No. EP2137535 (titled "Receptor Tyrosine Kinase Profiling") was filed by Dana Farber Cancer Institute on Apr 11, 2008. The application was issued on Jun 3, 2015.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ROCHE DIAGNOSTICS DEUTSCHLANDMar 3, 2016BOSL

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

EP2137535

DANA FARBER CANCER INSTITUTE
Application Number
EP08742858A
Filing Date
Apr 11, 2008
Status
Revoked
Publication Date
Jun 3, 2015